To examine the role of dectin-1-activated DCs in tumour immunotherapy in mice, we generated BMDCs and CurDCs from WT and dectin-1−/− mice, and pulsed them with OVA peptide (323–339). The gene discussed is CLEC7A; the disease is neoplasm.